Price
$2.02
Decreased by -1.46%
Dollar volume (20D)
428.88 K
ADR%
8.35
Earnings report date
May 6, 2025
Shares float
8.31 M
Shares short
764.36 K [9.20%]
Shares outstanding
46.29 M
Market cap
94.89 M
Beta
0.34
Price/earnings
N/A
20D range
1.77 2.90
50D range
1.77 3.81
200D range
1.21 3.81

Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes.

Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa.

The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway.

Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Mar 11, 25 -0.67
Decreased by -11.67%
-0.29
Decreased by -127.12%
Nov 6, 24 -0.46
Increased by +23.33%
-0.46
Aug 7, 24 -0.54
Increased by +19.40%
-0.69
Increased by +21.74%
May 8, 24 -0.68
Decreased by -19.30%
-0.64
Decreased by -6.25%
Mar 13, 24 -0.60
Decreased by -15.38%
-0.65
Increased by +7.69%
Nov 8, 23 -0.60
Increased by +11.76%
-0.72
Increased by +16.67%
Aug 9, 23 -0.67
Increased by +22.99%
-0.62
Decreased by -8.06%
May 10, 23 -0.57
Increased by +13.64%
-0.58
Increased by +1.72%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 24 7.24 M
Increased by +14.43%
-18.27 M
Decreased by -12.32%
Decreased by -252.42%
Increased by +1.85%
Sep 30, 24 7.21 M
Increased by +21.03%
-12.55 M
Increased by +23.04%
Decreased by -173.96%
Increased by +36.41%
Jun 30, 24 6.18 M
Decreased by -0.37%
-14.58 M
Increased by +18.85%
Decreased by -236.01%
Increased by +18.55%
Mar 31, 24 5.35 M
Decreased by -8.76%
-18.29 M
Decreased by -33.70%
Decreased by -341.66%
Decreased by -46.54%
Dec 31, 23 6.33 M
Increased by +21.03%
-16.27 M
Decreased by -16.94%
Decreased by -257.18%
Increased by +3.37%
Sep 30, 23 5.96 M
Increased by +40.38%
-16.30 M
Decreased by -22.40%
Decreased by -273.57%
Increased by +12.81%
Jun 30, 23 6.20 M
Increased by +80.45%
-17.97 M
Increased by +1.63%
Decreased by -289.76%
Increased by +45.49%
Mar 31, 23 5.87 M
Increased by +154.31%
-13.68 M
Increased by +1.59%
Decreased by -233.15%
Increased by +61.30%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY